Federal test of AI prior authorization delays care for seniors
Washington state hospitals report patients waiting two to four times longer for procedures subject to prior authorization under a new Medicare program....
Former tobacco executive joins CDC senior leadership, raising concerns
Stephen Sayle, a former tobacco industry executive, has been appointed to senior leadership at the Centers for Disease Control and Prevention....
STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
The American Association of Cancer Researchers' annual meeting saw discussions on various topics including Chinese biotech and communication issues in oncology. While the article primarily focuses on these topics, it doe...
Avoid men, German police association chief tells women
Police association chief Dirk Peglow has sparked controversy with his advice to women to avoid relationships with men for safety reasons. While some argue this is a reasonable precaution, others see it as sexist and misg...
Lebanon war puts pregnant women at risk
Displaced pregnant women struggle to access medical services due to Lebanon's strained healthcare system despite a temporary ceasefire between Israel and Hezbollah. Reuters reports this is partly because of the destructi...
US Military Drops Mandatory Flu Vaccine for Soldiers
The US military has made the flu vaccine no longer mandatory for soldiers, citing 'medical autonomy'. The decision comes after criticism of the mandate as 'overreaching'....
Grievance Turns to Violence in Mass Shooter's Mind
Attacks like last week's school shooting in Turkey often have a buildup of grievance and fixation before turning violent. Experts say understanding these factors can help prevent such incidents....
AACR 2026: CAR-T Controversy, Merck's China-Acquired Drug, and Oncology Access Gaps
Highlights from the American Association for Cancer Research annual meeting include a first look at a drug Merck acquired from China and a provocative new potential use for CAR-T therapy. The meeting also brought attenti...
Pfizer Chief Strategy Officer Andrew Baum Departs, Will Stay as Adviser
Pfizer confirmed that Andrew Baum, executive vice president and chief strategy and innovation officer, has left his role. Baum, a former Citi analyst who joined Pfizer in June 2024 to reshape the company's strategic dire...
CAR-T Therapy Trial Raises Hope of Preventing Multiple Myeloma in High-Risk Patients
Early trial results presented at the American Association for Cancer Research meeting suggest CAR-T immunotherapy may prevent smoldering multiple myeloma from progressing to active cancer. The findings offer new hope for...
Trump Signs Executive Order to Expand Access to Psychedelic Mental Health Treatments
President Trump signed an executive order aimed at loosening restrictions on psychedelics for mental health treatment, reportedly influenced in part by a text from podcaster Joe Rogan, who was present at the signing. The...
Eli Lilly Acquires Biotech Startup Kelonia Therapeutics for $3.25 Billion
Eli Lilly announced a $3.25 billion deal to acquire Kelonia Therapeutics, a small biotech developing cell therapies for cancer and autoimmune diseases, with potential additional milestone-based payments. The acquisition ...
PBMs Push Back Amid Ongoing Arbitration Disputes in Drug Pricing Battles
Pharmacy benefit managers (PBMs) are mounting a counteroffensive in ongoing disputes over drug pricing and reimbursement, as arbitration continues to play a central role in resolving conflicts. The newsletter-format arti...
New Data Validate KRAS as Druggable Target in Cancer Treatment
Researchers have made significant progress in targeting KRAS, a gene mutation long considered undruggable, with new clinical data validating emerging therapies. The development represents a major milestone in oncology dr...
Trump Backs Psychedelic Treatment; Weight-Loss Drug Access Concerns Emerge
The Trump administration has expressed support for psychedelic-based medical treatments, signaling a potential policy shift. Separately, analysts raise concerns that future weight-loss drugs may remain out of reach for m...
Cannabis Use Linked to Measurable Changes in Adolescent Brain Development
New research examines how marijuana affects the developing brains of teenagers, raising concerns about cognitive and neurological impacts. The findings add to a growing body of evidence on the risks of adolescent cannabi...
Nektar Therapeutics Drug Rezpeg Shows Extended Promise for Severe Alopecia
Nektar Therapeutics reported that extended treatment with its experimental drug rezpeg led to meaningful hair regrowth in 27% of participants with severe alopecia areata after one year of treatment. The results were comp...
HiPP Baby Food Recalled in Austria After Jar Found Contaminated with Rat Poison
Austrian baby food brand HiPP has recalled products after police reported that a tampered jar tested positive for rodent poison. The recall was prompted by safety concerns following the discovery of the contamination....
Sudan's Health System in Crisis as War Enters Fourth Year
Sudan's health ministry reports that 37 percent of the country's health facilities are out of service as the conflict stretches into its fourth year. A report from Al Jazeera highlights the dire situation inside the coun...
Governments Introduce Fuel Rations and Free Transit to Offset Rising Oil Prices
Countries worldwide are rolling out measures — including fuel rationing and free public bus services — to cushion consumers from the impact of rising oil prices. The article outlines the range of policy responses ado...